| 1 | pyrimidine nucleobase catabolic process (GO:0006208) | 8.57631760 |
| 2 | cellular response to vitamin (GO:0071295) | 7.10154883 |
| 3 | nucleobase catabolic process (GO:0046113) | 7.00284743 |
| 4 | response to UV-C (GO:0010225) | 6.96101863 |
| 5 | melanin biosynthetic process (GO:0042438) | 6.69724832 |
| 6 | negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518) | 6.63181240 |
| 7 | negative regulation of cell cycle arrest (GO:0071157) | 6.51820684 |
| 8 | melanin metabolic process (GO:0006582) | 6.20903317 |
| 9 | negative regulation of norepinephrine secretion (GO:0010700) | 6.11305879 |
| 10 | secondary metabolite biosynthetic process (GO:0044550) | 6.09144373 |
| 11 | embryonic camera-type eye development (GO:0031076) | 5.60003916 |
| 12 | hair cell differentiation (GO:0035315) | 5.54826205 |
| 13 | positive regulation of protein export from nucleus (GO:0046827) | 5.18210339 |
| 14 | response to magnesium ion (GO:0032026) | 5.07279267 |
| 15 | cell migration involved in heart development (GO:0060973) | 5.06062249 |
| 16 | positive regulation of G1/S transition of mitotic cell cycle (GO:1900087) | 5.01755247 |
| 17 | venous blood vessel morphogenesis (GO:0048845) | 4.95892186 |
| 18 | cellular response to antibiotic (GO:0071236) | 4.90655732 |
| 19 | ketone body metabolic process (GO:1902224) | 4.75143996 |
| 20 | ventricular cardiac muscle cell development (GO:0055015) | 4.73888542 |
| 21 | positive regulation of cell cycle G1/S phase transition (GO:1902808) | 4.69875643 |
| 22 | lung morphogenesis (GO:0060425) | 4.68464749 |
| 23 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 4.65958450 |
| 24 | left/right axis specification (GO:0070986) | 4.60988224 |
| 25 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 4.59198711 |
| 26 | central nervous system projection neuron axonogenesis (GO:0021952) | 4.26056158 |
| 27 | negative regulation of catecholamine secretion (GO:0033604) | 4.13024369 |
| 28 | cellular response to toxic substance (GO:0097237) | 4.11967238 |
| 29 | protein K11-linked deubiquitination (GO:0035871) | 4.08383520 |
| 30 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 4.00783960 |
| 31 | female gonad development (GO:0008585) | 3.91937862 |
| 32 | melanosome organization (GO:0032438) | 3.84620619 |
| 33 | regulation of penile erection (GO:0060405) | 3.71110691 |
| 34 | pigment granule organization (GO:0048753) | 3.70949985 |
| 35 | negative regulation of signal transduction by p53 class mediator (GO:1901797) | 3.58936040 |
| 36 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.53708410 |
| 37 | central nervous system neuron axonogenesis (GO:0021955) | 3.48342090 |
| 38 | male meiosis (GO:0007140) | 3.45357595 |
| 39 | ganglion development (GO:0061548) | 3.41222948 |
| 40 | ventricular septum morphogenesis (GO:0060412) | 3.38903761 |
| 41 | nerve growth factor signaling pathway (GO:0038180) | 3.38075106 |
| 42 | sympathetic nervous system development (GO:0048485) | 3.37726521 |
| 43 | synaptonemal complex assembly (GO:0007130) | 3.33737021 |
| 44 | exocrine pancreas development (GO:0031017) | 3.31014800 |
| 45 | synaptonemal complex organization (GO:0070193) | 3.27431894 |
| 46 | melanocyte differentiation (GO:0030318) | 3.26388974 |
| 47 | regulation of norepinephrine secretion (GO:0014061) | 3.23936537 |
| 48 | response to cocaine (GO:0042220) | 3.23885703 |
| 49 | phenol-containing compound biosynthetic process (GO:0046189) | 3.21610053 |
| 50 | olfactory bulb development (GO:0021772) | 3.20406485 |
| 51 | digestive tract morphogenesis (GO:0048546) | 3.17106065 |
| 52 | postsynaptic membrane organization (GO:0001941) | 3.14878851 |
| 53 | retinal ganglion cell axon guidance (GO:0031290) | 3.08729230 |
| 54 | piRNA metabolic process (GO:0034587) | 3.06746296 |
| 55 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 3.06497572 |
| 56 | response to iron ion (GO:0010039) | 3.05603464 |
| 57 | short-chain fatty acid metabolic process (GO:0046459) | 3.05178326 |
| 58 | dentate gyrus development (GO:0021542) | 3.04914710 |
| 59 | cellular response to nutrient (GO:0031670) | 3.04632305 |
| 60 | neuron recognition (GO:0008038) | 3.01830807 |
| 61 | pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174) | 2.99687313 |
| 62 | UMP metabolic process (GO:0046049) | 2.99687313 |
| 63 | pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173) | 2.99687313 |
| 64 | UMP biosynthetic process (GO:0006222) | 2.99687313 |
| 65 | peristalsis (GO:0030432) | 2.97380641 |
| 66 | response to vitamin A (GO:0033189) | 2.94269258 |
| 67 | neuroepithelial cell differentiation (GO:0060563) | 2.92291958 |
| 68 | pigment cell differentiation (GO:0050931) | 2.90889225 |
| 69 | myoblast fusion (GO:0007520) | 2.90614840 |
| 70 | protein destabilization (GO:0031648) | 2.90370175 |
| 71 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.87171236 |
| 72 | embryonic digestive tract morphogenesis (GO:0048557) | 2.86930815 |
| 73 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.85753561 |
| 74 | regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516) | 2.84613237 |
| 75 | positive regulation of developmental pigmentation (GO:0048087) | 2.83478406 |
| 76 | DNA damage response, detection of DNA damage (GO:0042769) | 2.81732782 |
| 77 | regulation of protein export from nucleus (GO:0046825) | 2.80668137 |
| 78 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.79817490 |
| 79 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.79693951 |
| 80 | rRNA methylation (GO:0031167) | 2.78090052 |
| 81 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.75047783 |
| 82 | phasic smooth muscle contraction (GO:0014821) | 2.73400444 |
| 83 | inositol phosphate catabolic process (GO:0071545) | 2.73273415 |
| 84 | ncRNA catabolic process (GO:0034661) | 2.70735046 |
| 85 | regulation of telomere maintenance via telomerase (GO:0032210) | 2.69616138 |
| 86 | regulation of hexokinase activity (GO:1903299) | 2.69040455 |
| 87 | regulation of glucokinase activity (GO:0033131) | 2.69040455 |
| 88 | opioid receptor signaling pathway (GO:0038003) | 2.69018686 |
| 89 | cellular response to estrogen stimulus (GO:0071391) | 2.68322874 |
| 90 | neural crest cell migration (GO:0001755) | 2.66610037 |
| 91 | brain morphogenesis (GO:0048854) | 2.66575366 |
| 92 | replication fork processing (GO:0031297) | 2.65859017 |
| 93 | rRNA catabolic process (GO:0016075) | 2.64093677 |
| 94 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.63800285 |
| 95 | rRNA modification (GO:0000154) | 2.62993480 |
| 96 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.61451424 |
| 97 | neuron fate determination (GO:0048664) | 2.61245834 |
| 98 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 2.61153535 |
| 99 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.60168803 |
| 100 | anterograde synaptic vesicle transport (GO:0048490) | 2.59716318 |
RPL31P58 
